NCT01753362View on ClinicalTrials.gov

Liraglutide In Overweight Patients With Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

February 28, 2018

Conditions
Type 1 Diabetes
Interventions
DRUG

liraglutide

DRUG

placebo

Trial Locations (2)

14215

diabetes endocrinology center of WNY, Buffalo

Diabetes Endocrinology Research Center of WNY, Buffalo

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University at Buffalo

OTHER